Incidental Mutation 'R6337:Vipr2'
ID 513769
Institutional Source Beutler Lab
Gene Symbol Vipr2
Ensembl Gene ENSMUSG00000011171
Gene Name vasoactive intestinal peptide receptor 2
Synonyms VPAC2R, VPAC2, VIP receptor subtype 2, Vip2
MMRRC Submission 044491-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.068) question?
Stock # R6337 (G1)
Quality Score 225.009
Status Validated
Chromosome 12
Chromosomal Location 116041346-116109881 bp(+) (GRCm39)
Type of Mutation nonsense
DNA Base Change (assembly) T to A at 116086363 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Tyrosine to Stop codon at position 129 (Y129*)
Ref Sequence ENSEMBL: ENSMUSP00000011315 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000011315]
AlphaFold P41588
Predicted Effect probably null
Transcript: ENSMUST00000011315
AA Change: Y129*
SMART Domains Protein: ENSMUSP00000011315
Gene: ENSMUSG00000011171
AA Change: Y129*

DomainStartEndE-ValueType
signal peptide 1 19 N/A INTRINSIC
HormR 47 117 8.35e-25 SMART
Pfam:7tm_2 122 370 1.5e-81 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000175871
Predicted Effect noncoding transcript
Transcript: ENSMUST00000176078
Predicted Effect noncoding transcript
Transcript: ENSMUST00000177059
Predicted Effect noncoding transcript
Transcript: ENSMUST00000177199
Meta Mutation Damage Score 0.9711 question?
Coding Region Coverage
  • 1x: 99.9%
  • 3x: 99.6%
  • 10x: 98.0%
  • 20x: 94.1%
Validation Efficiency 98% (61/62)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase. [provided by RefSeq, Aug 2011]
PHENOTYPE: Homozygotes for a targeted null mutation exhibit enhanced delayed-type hypersensitivity (type IV) and reduced immediate-type hypersensitivity (type I). [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 62 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
4933434E20Rik T G 3: 89,969,040 (GRCm39) V221G probably benign Het
Abca12 G A 1: 71,334,172 (GRCm39) A1110V probably damaging Het
Acsl6 C A 11: 54,231,368 (GRCm39) P462T probably damaging Het
Acsm5 G A 7: 119,133,458 (GRCm39) A208T probably benign Het
Adcyap1 T A 17: 93,509,709 (GRCm39) Y53* probably null Het
Adgrg7 T A 16: 56,572,788 (GRCm39) I343F probably damaging Het
Agl T A 3: 116,580,426 (GRCm39) K376M possibly damaging Het
Akna A G 4: 63,292,240 (GRCm39) Y1142H probably benign Het
Anks1b A T 10: 90,757,158 (GRCm39) T182S probably benign Het
Apol7e T A 15: 77,598,582 (GRCm39) Y16N possibly damaging Het
Bptf G T 11: 106,949,605 (GRCm39) T2238K possibly damaging Het
Ccdc87 A G 19: 4,889,829 (GRCm39) E107G probably benign Het
Ccng2 C T 5: 93,418,780 (GRCm39) A135V probably benign Het
Chd8 C A 14: 52,441,566 (GRCm39) R842L probably damaging Het
Cldn18 T A 9: 99,591,995 (GRCm39) T3S probably benign Het
Dhcr7 T C 7: 143,390,468 (GRCm39) probably null Het
Dnah8 G A 17: 30,967,542 (GRCm39) D2585N probably benign Het
Dusp26 T C 8: 31,586,325 (GRCm39) V182A probably damaging Het
Eif3e T C 15: 43,115,692 (GRCm39) D358G possibly damaging Het
Epha3 A T 16: 63,388,806 (GRCm39) L814H probably damaging Het
Flnc A G 6: 29,454,318 (GRCm39) N1877S probably damaging Het
Fpgs A T 2: 32,577,953 (GRCm39) Y156* probably null Het
Gm10549 C A 18: 33,597,358 (GRCm39) probably benign Het
Gm11595 G A 11: 99,663,381 (GRCm39) R100C unknown Het
Gm5591 T C 7: 38,221,319 (GRCm39) D250G probably benign Het
Gtf2e2 C T 8: 34,266,043 (GRCm39) R240* probably null Het
Hells G T 19: 38,943,254 (GRCm39) Q519H probably benign Het
Hscb A G 5: 110,987,360 (GRCm39) probably null Het
Inpp5k T A 11: 75,537,640 (GRCm39) I350N probably damaging Het
Irf9 G A 14: 55,843,799 (GRCm39) V221I possibly damaging Het
Itga8 A T 2: 12,258,280 (GRCm39) Y261* probably null Het
Itprid2 G A 2: 79,485,463 (GRCm39) D506N probably damaging Het
Lama1 C T 17: 68,093,014 (GRCm39) T1684M probably benign Het
Lrp2 A T 2: 69,268,811 (GRCm39) H4157Q probably damaging Het
Nceh1 G T 3: 27,276,956 (GRCm39) R93L probably damaging Het
Nell2 A G 15: 95,283,025 (GRCm39) F339S probably damaging Het
Or2t49 A T 11: 58,392,838 (GRCm39) C181* probably null Het
Phf11a C A 14: 59,521,817 (GRCm39) C118F probably damaging Het
Purg A G 8: 33,876,451 (GRCm39) K30E possibly damaging Het
Qprt C T 7: 126,708,101 (GRCm39) R110H probably damaging Het
Robo2 T C 16: 73,725,039 (GRCm39) T1055A probably benign Het
Serpina3a T C 12: 104,079,137 (GRCm39) F10L probably benign Het
Sidt1 A T 16: 44,121,298 (GRCm39) probably null Het
Slc4a4 T A 5: 89,194,231 (GRCm39) M237K probably benign Het
Slitrk5 A T 14: 111,917,684 (GRCm39) D436V probably damaging Het
Snd1 T C 6: 28,888,288 (GRCm39) Y908H probably damaging Het
Sorcs1 A G 19: 50,132,562 (GRCm39) V1132A probably benign Het
Speer3 A G 5: 13,843,369 (GRCm39) E92G probably damaging Het
Strada T C 11: 106,064,143 (GRCm39) E58G possibly damaging Het
Tbx10 A T 19: 4,047,312 (GRCm39) K139* probably null Het
Tcf4 T C 18: 69,766,651 (GRCm39) Y25H probably damaging Het
Tmem108 C T 9: 103,376,960 (GRCm39) R163H possibly damaging Het
Top2b A G 14: 16,399,026 (GRCm38) T549A possibly damaging Het
Tpcn2 A G 7: 144,833,080 (GRCm39) I46T probably damaging Het
Uox C T 3: 146,330,332 (GRCm39) R163* probably null Het
Vps37a A T 8: 40,993,749 (GRCm39) Q248L probably benign Het
Wrap53 T C 11: 69,468,511 (GRCm39) I179V probably benign Het
Zan G A 5: 137,450,750 (GRCm39) A1609V unknown Het
Zbtb17 G A 4: 141,190,694 (GRCm39) G171S probably benign Het
Zbtb5 G A 4: 44,993,459 (GRCm39) R642W probably damaging Het
Zfyve27 A G 19: 42,171,096 (GRCm39) probably null Het
Zup1 T C 10: 33,825,252 (GRCm39) N77D probably benign Het
Other mutations in Vipr2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00691:Vipr2 APN 12 116,102,368 (GRCm39) splice site probably null
IGL02233:Vipr2 APN 12 116,058,356 (GRCm39) missense probably damaging 0.99
IGL02691:Vipr2 APN 12 116,099,849 (GRCm39) missense probably benign 0.11
PIT4377001:Vipr2 UTSW 12 116,058,418 (GRCm39) missense probably benign 0.01
R0135:Vipr2 UTSW 12 116,106,447 (GRCm39) missense probably benign 0.00
R0207:Vipr2 UTSW 12 116,106,502 (GRCm39) missense probably damaging 1.00
R1389:Vipr2 UTSW 12 116,100,950 (GRCm39) missense probably benign 0.01
R1560:Vipr2 UTSW 12 116,058,401 (GRCm39) missense probably benign 0.18
R1575:Vipr2 UTSW 12 116,107,892 (GRCm39) missense probably benign
R1696:Vipr2 UTSW 12 116,102,777 (GRCm39) missense probably benign 0.13
R1970:Vipr2 UTSW 12 116,099,826 (GRCm39) missense probably benign 0.01
R2010:Vipr2 UTSW 12 116,086,430 (GRCm39) critical splice donor site probably null
R3873:Vipr2 UTSW 12 116,099,724 (GRCm39) unclassified probably benign
R4713:Vipr2 UTSW 12 116,043,751 (GRCm39) missense probably benign 0.00
R4953:Vipr2 UTSW 12 116,107,876 (GRCm39) missense probably benign 0.07
R6041:Vipr2 UTSW 12 116,106,604 (GRCm39) missense probably damaging 1.00
R6902:Vipr2 UTSW 12 116,102,819 (GRCm39) missense possibly damaging 0.46
R6946:Vipr2 UTSW 12 116,102,819 (GRCm39) missense possibly damaging 0.46
R7763:Vipr2 UTSW 12 116,086,338 (GRCm39) missense probably damaging 1.00
R9339:Vipr2 UTSW 12 116,058,344 (GRCm39) missense probably damaging 0.96
R9523:Vipr2 UTSW 12 116,093,788 (GRCm39) missense probably damaging 1.00
X0066:Vipr2 UTSW 12 116,106,565 (GRCm39) splice site probably null
X0067:Vipr2 UTSW 12 116,102,792 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- AAAATGACCCTGTCTCCTGTC -3'
(R):5'- TCTCTATAGGTTGGTACACAGAGG -3'

Sequencing Primer
(F):5'- GCACTTGGCATGCAAGAG -3'
(R):5'- GGGTCAAGAGTCTAAACCTCTG -3'
Posted On 2018-04-27